Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 131,762 | 43,313 | -29,781 | 70,726 | 3,896 |
| Depreciation Amortization | 16,225 | 6,944 | 2,892 | 420 | 439 |
| Income taxes - deferred | 87,378 | -103,202 | N/A | N/A | N/A |
| Accounts receivable | -5,283 | -8,564 | -1,136 | -6,208 | -1,414 |
| Other Working Capital | -71,958 | 69,087 | -9,686 | -16,555 | -9,084 |
| Other Operating Activity | -214,041 | 2,176 | 6,726 | 9,268 | 3,782 |
| Operating Cash Flow | $-55,917 | $9,754 | $-30,985 | $57,651 | $-2,381 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -599 | -1,812 | -6,880 | -698 | -179 |
| Net Acquisitions | N/A | -52,725 | -26,435 | N/A | N/A |
| Purchase Of Investment | -73,754 | -37,746 | -38,462 | -195,162 | -71,325 |
| Sale Of Investment | 27,046 | 54,397 | 105,109 | 133,672 | 72,016 |
| Purchase Sale Intangibles | N/A | -150 | 0 | 0 | N/A |
| Other Investing Activity | 0 | -150 | 0 | 0 | 0 |
| Investing Cash Flow | $-47,307 | $-38,036 | $33,332 | $-62,188 | $512 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 345,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | N/A | N/A | -2,244 | -3,843 |
| Common Stock Issued | 9,803 | 3,727 | 2,686 | 8,298 | 1,417 |
| Other Financing Activity | -7,585 | 240,153 | 0 | 0 | 0 |
| Financing Cash Flow | $347,218 | $243,880 | $2,686 | $6,054 | $-2,426 |
| Beginning Cash Position | 244,674 | 29,076 | 24,043 | 22,526 | 26,821 |
| End Cash Position | 488,668 | 244,674 | 29,076 | 24,043 | 22,526 |
| Net Cash Flow | $243,994 | $215,598 | $5,033 | $1,517 | $-4,295 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,917 | 9,754 | -30,985 | 57,651 | -2,381 |
| Capital Expenditure | -599 | -1,812 | -6,880 | -698 | -179 |
| Free Cash Flow | -56,516 | 7,942 | -37,865 | 56,953 | -2,560 |